Dyslipidemia in peritoneal dialysis - Relation to dialytic variables

Peritoneal Dialysis International

Volumn 20, Issue 3, 2000, Pages 306-314

  Johansson, A C ^a   Samuelsson, O ^a   Attman, P O ^a   Haraldsson, B ^a   Moberly, J ^a   Knight Gibson, C ^a   Alaupovic, P ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Apolipoproteins; Lipids; Peritoneal transport

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; APOLIPOPROTEIN B; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BODY SURFACE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DYSLIPIDEMIA; FEMALE; GLUCOSE TRANSPORT; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEIN DEPLETION; SWEDEN; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0033943302     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080002000307     Document Type: Article

References (49)

1. Lipid metabolism and renal failure
2. ApoB-containing lipoproteins in renal failure - The relation to mode of dialysis
3. Abnormalities of lipoprotein metabolism in CAPD patients
4. Kinetics of peritoneal protein loss during CAPD: II. Lipoprotein leakage and its impact on plasma lipid levels
5. Effects of the three treatment modes on plasma lipids and lipoproteins in uremic patients
6. Triglyceride-rich lipoprotein abnormalities in CAPD-treated patients
7. Hyper-apo-betalipoproteinemia: The major dyslipoproteinemia in patients with chronic renal failure treated with chronic ambulatory peritoneal dialysis
8. Lipid parameters including lipoprotein (a) in patients undergoing CAPD and hemodialysis
9. AIV in plasma and dialysate fluid of CAPD patients: Comparison with other apolipoproteins
10. Impaired metabolism of high density lipoprotein in uremic patients
11. The uremic dyslipidemia: A cross-sectional and longitudinal study
12. Cholesteryl ester transfer in patients with renal failure or renal transplants
13. Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients
14. Studies on the mechanism of hypertriglyceridemia in Tangier disease: Determination of plasma lipolytic activities, ki values and apolipoprotein composition of the major lipoprotein density classes
15. A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol
16. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
17. Determination of apolipoprotein A and its constitutive AI and AII polypeptides by separate electroimmunoassays
18. Electroimmunoassay, radioimmunoassay and radial immunodiffusion assay evaluated for quantification of human apolipoprotein B
19. Quantitative determination of apolipoprotein C-III by electroimmunoassay
20. Determination of human apolipoprotein E by electroimmunoassay
21. Serum apolipoprotein profile of patients with chronic renal failure
22. Differential electroimmunoassay of human LP-AI lipoprotein particles on ready-to-use plates
23. Effects of lovastation on apoA- and apoB-containing lipoprotein families in a subpopulation of patients participating in the Monitored Atherosclerosis Regression Study (MARS)
24. Assessing the peritoneal dialysis capacities of individual patients
25. Clinical value of standardized equilibration tests in CAPD patients
26. Estimation of peritoneal mass transport by three-pore model in children
27. Clinical application of the personal dialysis capacity (PDC) test: Serial analysis of peritoneal function in CAPD patients
28. Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiency
29. Sequential changes in serum lipids and their subfractions in patients receiving continuous ambulatory peritoneal dialysis
30. Effects of long-term CAPD on carbohydrate and lipid metabolism
31. Longitudinal lipid profiles on CAPD: Their relationship to weight gain, comorbidity, and dialysis factors
32. Serum lipids and lipoproteins during continous ambulatory peritoneal dialysis
33. The lipoprotein family concept and its clinical significance
34. Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five year follow-up of men in the Quebec Cardiovascular Study
35. Measurement of apoproteins: Time to improve the diagnosis and treatment of the atherogenic dyslipoproteinemias
36. Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts: Lipid and non-lipid factors
37. Increased plasma lipoprotein (a) in continous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose
38. Lipids in CAPD: A review
39. Lipid abnormalities in the nephrotic syndrome: Causes, consequences and treatment
40. Albumin homeostasis in patients undergoing continuous ambulatory peritoneal dialysis
41. Decreased clearance of low-density lipoprotein in uremic patients under dialysis treatment
42. Lipid and apolipoprotein profiles of uremic dyslipoproteinemia-relation to renal function and dialysis
43. Lipoprotein metabolism in normal and uremic patients
44. Lipoprotein and apolipoprotein losses during continous ambulatory peritoneal dialysis
45. The relationship between plasma and dialysate lipoproteins and apoproteins in patients treated by continous ambulatory peritoneal dialysis
46. Kinetics of peritoneal protein loss during continuous ambulatory peritoneal dialysis (CAPD): I. Different characteristics for peritoneal loss of low and high molecular weight proteins
47. How does peritoneal dialysis remove small and large molecular solutes? Transport pathways: Fact and myth
48. Computer simulations of peritoneal fluid transport in CAPD
49. Differential endocytosis of lipoproteins by capillary endothelial vesicles